Early-Stage HCC Percutaneous Locoregional Management: East versus West Perspectives

Hepatocellular carcinoma represents an important cause of death worldwide. Early-stage hepatocellular carcinoma patients not suitable for surgery can be treated with a variety of minimally invasive locoregional interventional oncology techniques. Various guidelines in different countries address the...

Full description

Saved in:
Bibliographic Details
Published in:Cancers 2023-08, Vol.15 (15), p.3988
Main Authors: Iezzi, Roberto, Posa, Alessandro, Contegiacomo, Andrea, Lee, In Joon, Bale, Reto, Tanzilli, Alessandro, Tenore, Lorenzo, Giuliante, Felice, Gasbarrini, Antonio, Goldberg, Shraga Nahum, Jakobs, Tobias, Pompili, Maurizio, Bargellini, Irene, Sala, Evis, Kim, Hyo-Cheol
Format: Article
Language:English
Subjects:
Ablation
Ablation (Surgery)
Cancer
Cancer therapies
Care and treatment
Electrodes
Evidence-based medicine
Hepatocellular carcinoma
Liver cancer
Oncology
Patients
Review
Surgery
Tumors
Ultrasonic imaging
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Hepatocellular carcinoma represents an important cause of death worldwide. Early-stage hepatocellular carcinoma patients not suitable for surgery can be treated with a variety of minimally invasive locoregional interventional oncology techniques. Various guidelines in different countries address the treatment of hepatocellular carcinoma, but the actual treatment is usually discussed by a multidisciplinary tumor board in a personalized manner, leading to potential treatment differences based on Western and Eastern perspectives. The aim of this paper is to integrate literature evidence with the eminent experiences collected during a focused session at the Mediterranean Interventional Oncology (MIO) Live Congress 2023.
ISSN:2072-6694
2072-6694
DOI:10.3390/cancers15153988